
Miglirab 20mg Tablet
Marketer
Migliore Life Sciences
Salt Composition
Rabeprazole (20mg)
Overview Miglirab 20mg Tablet
Acid-reducing medication, Gastracid 20mg tablets, lessens stomach acid production. It treats stomach and intestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, easing symptoms and promoting healing. Take one Gastracid 20mg tablet an hour before meals, ideally in the morning, as directed by your physician; dosage depends on your condition and response. Maintain consistent daily intake, even if symptoms improve rapidly. Smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods may help. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Report persistent or bothersome side effects. Prolonged use (over a year), especially at higher doses, may increase bone fracture risk. Discuss bone loss prevention, including calcium and vitamin D supplements, with your doctor. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor might monitor your magnesium levels. Gastracid 20mg tablets aren't suitable for everyone. Inform your doctor of severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or existing osteoporosis before use. Pregnant or breastfeeding individuals should consult their physician. Alcohol should be avoided due to its acid-increasing effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Miglirab 20mg Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Miglirab 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Miglirab 20mg Tablets should be taken on an empty stomach.
Common Side effects of Miglirab 20mg Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Miglirab 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 20mg Miglirab tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Miglirab 20mg Tablet works:
StomaCalm 20mg tablets are proton pump inhibitors that decrease stomach acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Miglirab 20mg Tablets requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Miglirab 20mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Miglirab 20mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Miglirab 20mg tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Miglirab 20mg tablets are considered safe, and no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
For individuals with hepatic impairment, Miglirab 20mg tablets are considered safe for administration. No modification of the Miglirab 20mg tablet dosage is necessary.
What if you forget to take Miglirab 20mg Tablet :
Should you forget a Miglirab 20mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual regimen. Never take a double dose.
Facts to Know About Miglirab 20mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
